Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2007
10/25/2007WO2007120936A2 Use.of vildagliptin for the treatment of diabetes
10/25/2007WO2007120454A1 Azolopyrimidines as inhibitors of cannabinoid 1 activity
10/25/2007WO2007120284A2 Glucagon receptor antagonists, preparation and therapeutic uses
10/25/2007WO2007119887A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ
10/25/2007WO2007119837A1 Lipase inhibitor
10/25/2007WO2007119833A1 Nitrogen-containing heterocyclic compound
10/25/2007WO2007119693A1 Lactic acid bacterium-derived composition for ppar-dependent gene transcription activation
10/25/2007WO2007119684A1 Spraying agent
10/25/2007WO2007119623A1 Novel use of g-protein-conjugated receptor and ligand thereof
10/25/2007WO2007119467A1 Percutaneous absorption promoting agent and percutaneous absorption preparation using the same
10/25/2007WO2007119367A1 Composition containing biopterin and method for using the same
10/25/2007WO2007119085A1 Rosuvastatin zinc salt
10/25/2007WO2007118964A1 Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof
10/25/2007WO2007118873A2 Polymorphs of atorvastatin sodium and magnesium salts
10/25/2007WO2007118368A1 A pharmaceutical tea for reducing blood sugar and process thereof
10/25/2007WO2007101864A3 Compounds that modulate ppar activity, their preparation and use
10/25/2007WO2007077508A3 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
10/25/2007WO2007041368A3 Dpp iv inhibitor for use in the treatment of autoimmune diseases and graft rejection
10/25/2007WO2007041112A3 Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
10/25/2007WO2006103342A9 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249719 Compounds for the treatment of metabolic disorders
10/25/2007US20070249703 (Hydroxyphenyl)-1H-Indole-3-Carbaldehyde Oxime Derivatives As Estrogenic Agents
10/25/2007US20070249696 Compounds for the treatment of metabolic disorders
10/25/2007US20070249692 Inhibitors of crystallization in a solid dispersion
10/25/2007US20070249688 3-{4-[1-(4'-tert-butyl-2,6-dimethyl-biphenyl-4-yloxy)-4,4,4-trifluoro-butyl]-benzoylamino}-propionic acid; treat diabetic and other glucagon related metabolic disorders
10/25/2007US20070249663 Corticotropin-Releasing Factor (CRF) receptor antagonist as therapeutic agent for depression, depressive symptom, or irritable bowel syndrome
10/25/2007US20070249661 Compounds for inflammation and immune-related uses
10/25/2007US20070249659 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
10/25/2007US20070249653 Tetracyclic benzamide derivatives and methods of use thereof
10/25/2007US20070249645 Such as N-(3-Benzyloxy-phenyl)-N-(4-thiazol-2-yl-pyrimidin-2-yl)-amine; allergic diseases, cancer, neurodegenerative and proliferative disorders, diabetes; inhibitors of GSK-3, Aurora2, and Syk protein kinases
10/25/2007US20070249620 Urea Derivative
10/25/2007US20070249616 Substituted 1-Benzyl-4-Substituted Piperazine Analogues
10/25/2007US20070249598 selective antagonists of A2B adenosine receptors; for improving insulin sensitivity; asthma
10/25/2007US20070249587 Aromatic-Ring-Fused Pyrimidine Derivative
10/25/2007US20070249580 Novel Cyclic Amino Benzoic Acid Derivative
10/25/2007US20070249570 Homogeneously formulating microdosed active principles
10/25/2007US20070249004 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule
10/25/2007US20070248698 Obesity and Metabolic Syndrome Treatment with Tanshinone Derivatives Which Increase Metabolic Activity
10/25/2007US20070248686 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
10/25/2007US20070248663 Utilization of Dialkylfumerates
10/25/2007US20070248662 Immunosuppressants; for use in transplantation medicine or treatment of autoimmune diseases such as polyarthritis but not psoriatitc arthritis; micro-tablets, pellets
10/25/2007US20070248652 Nutritional Food and Feed, Compostition, Processing and Method of Use
10/25/2007US20070248617 Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides
10/25/2007US20070248611 Methods wanted for treating unwanted weight loss or eating disorders by administering a trkb agonist
10/25/2007US20070248590 Modulators of CDC2-like kinases (CLKS) and methods of use thereof
10/25/2007DE102006018912A1 1,4:3,6-Dianhydromannitol-Derivate und deren Verwendung 1,4: 3,6-Dianhydromannitol derivatives and their use
10/25/2007CA2649735A1 Activating agent for peroxisome proliferator activated receptor .delta.
10/25/2007CA2649710A1 Use of opioid antagonists to attenuate endothelial cell proliferation and migration
10/25/2007CA2649706A1 Cell therapy: a method and a composition for treating diabetes
10/25/2007CA2649700A1 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
10/25/2007CA2649219A1 Rosuvastatin zinc salt
10/25/2007CA2649109A1 Rapid acting and long acting insulin combination formulations
10/25/2007CA2648748A1 Nitrogen-containing heterocyclic compound
10/25/2007CA2648642A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/25/2007CA2635399A1 Use.of vildagliptin for the treatment of diabetes
10/25/2007CA2629311A1 Glucagon receptor antagonists, preparation and therapeutic uses
10/25/2007CA2629172A1 Glucagon receptor antagonists, preparation and therapeutic uses
10/24/2007EP1847614A1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virions (raav virions), and method and use for treating amino acid metabolic disorders using such raav virions
10/24/2007EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/24/2007EP1847548A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
10/24/2007EP1847531A1 Pyrazole compound
10/24/2007EP1847530A1 Diamine derivative
10/24/2007EP1847271A2 Water-absorbent polymers and their use as a medicament
10/24/2007EP1847266A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
10/24/2007EP1847263A2 Inhibitors against the production and release of inflammatory cytokines
10/24/2007EP1847244A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
10/24/2007EP1846453A2 Inhibition of islet amyloid polypeptide (iapp) aggregation for the treatment of type 2 diabetes
10/24/2007EP1846452A1 Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 )
10/24/2007EP1846415A1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
10/24/2007EP1846413A2 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
10/24/2007EP1846410A2 Dihydroquinazolinones as 5ht modulators
10/24/2007EP1846391A2 Raf inhibitor compounds and methods
10/24/2007EP1846389A1 Imidazole derivatives
10/24/2007EP1846379A1 Antidiabetic bicyclic compounds
10/24/2007EP1846363A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/24/2007EP1846362A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/24/2007EP1846037A1 Methods of treating various conditions by administration of sustained release l-arginine
10/24/2007EP1846035A2 Combination therapy
10/24/2007EP1846002A1 Method for blood glucose control in a mammal by n-acylated glucosamines
10/24/2007EP1845999A1 Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-rerelated diseases
10/24/2007EP1845977A1 Oral dosage form comprising rosiglitazone
10/24/2007EP1845952A2 Stable tablet formulation of tetrahydrobiopterin
10/24/2007EP1606307B1 Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/24/2007EP1478401A4 Compositions comprising dietary fat complexer and methods for their use
10/24/2007EP1365771B1 Method of treating certain eye diseases
10/24/2007EP1218348B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/24/2007EP1207860B1 Controlled release pellet formulation
10/24/2007CN101060862A Composition for oral or rectal administration
10/24/2007CN101060854A Protein hydrolysate with antidiabetic effect
10/24/2007CN101060836A New use for cannabinoid
10/24/2007CN101058832A Method for detecting growth hormone variations in humans, the variations and their uses
10/24/2007CN101058810A Amphioxus uncoupling protein gene and application thereof
10/24/2007CN101058558A 4-Oxy-1(4H)-quinoline carboxylic acids compound and composition with aldose reductase inhibition activity and preparation method thereof
10/24/2007CN101058556A Diphenylacetidinon derivatives for treatment of disordered lipid metabolism, method of production thereof(variants), pharmaceutical composition
10/24/2007CN101057976A Substances for preventing and treating autoimmune diseases
10/24/2007CN101057972A Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
10/24/2007CN101057968A Oxyntomodulin for preventing or treating excess weight
10/24/2007CN101057942A External applied medicine ointment for treating diabetes foot and its preparing method
10/24/2007CN101057941A Medicine for treating diabetes and its preparation method
1 ... 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 ... 1298